Nymox's NX-1207 to be Clinically Tested for Prostate Cancer

Full story: GlobeNewswire

Nymox Pharmaceutical Corporation is pleased to announce that NX-1207, the Company's lead drug in development, has been shown to produce strongly positive and repeatable results in laboratory studies of human prostate cancer.

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Benign Prostatic Hyperplasia Discussions

Topic	Updated	Last By	Comments
a natural sultion for prostatic hyperplasia	Sep '09	OMRIE	1
Dad can't urinate--NEED ADVICE! (Apr '09)	Apr '09	ConcernedAbo...	1
BioXell announces positive Phase IIb results fo... (Nov '07)	Nov '07	ELO	2
BPH - Post Surgery Problems (Dec '06)	Dec '06	Sweta	1
Adding Flomax Or Hytrin To Viagra Does Not Indu... (Apr '06)	Apr '06	ras	1
Protect Your Prostate	Mar '06	W Mullins	1
Doxazosin Plus Finasteride Reduced Clinical Pro...	Feb '06	nermeen	1